• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

唑类化合物和三唑类抗真菌药物的基本概念:初学者综述

Fundamental Concepts of Azole Compounds and Triazole Antifungals: A Beginner's Review.

作者信息

Martínez-Matías Nelson, Rodríguez-Medina José R

机构信息

Department of Biochemistry, University of Puerto Rico Medical Sciences Campus, San Juan, PR.

出版信息

P R Health Sci J. 2018 Sep;37(3):135-142.

PMID:30188556
Abstract

Azoles are the most widely used drugs in antifungal therapy. They have a wide spectrum of activity against pathogenic fungi that are clinically relevant. However, they have been associated with adverse reactions and toxicity, both of which can be significant in patients. Compared to diazoles, triazoles discriminate better between their intended molecular target, the fungal CYP51 enzyme, and several enzymes of the human CYP450 system. Over the years, this superior discrimination has led to the favoring of triazoles over diazoles in the treatment of systemic mycoses. Nevertheless, despite their being better able to discriminate between the fungal CYP51 and host CYP450 enzymes, they are still capable of inducing significant toxicity and adverse reactions in the host, especially when taken concomitantly with other therapeutic drugs by patients with compromised immune systems. In this writing, we review some of the fundamental concepts regarding the chemistry and mechanisms of action of azole compounds, as well as the spectrum of activity, pharmacokinetics, and adverse effects of triazole antifungals. In addition, we discuss some of the mechanisms that pathogenic fungi have developed to overcome the cytotoxic effects of therapeutic drugs, with an emphasis on triazoles.

摘要

唑类药物是抗真菌治疗中使用最广泛的药物。它们对临床上相关的致病真菌具有广泛的活性。然而,它们与不良反应和毒性有关,这两者在患者中都可能很严重。与二唑类相比,三唑类在其预期的分子靶点真菌CYP51酶和人类CYP450系统的几种酶之间具有更好的区分能力。多年来,这种卓越的区分能力使得在系统性真菌病的治疗中三唑类比二唑类更受青睐。尽管如此,尽管它们能够更好地区分真菌CYP51和宿主CYP450酶,但它们仍然能够在宿主中引起显著的毒性和不良反应,尤其是当免疫系统受损的患者同时服用其他治疗药物时。在本文中,我们回顾了一些关于唑类化合物的化学和作用机制的基本概念,以及三唑类抗真菌药物的活性谱、药代动力学和不良反应。此外,我们讨论了致病真菌为克服治疗药物的细胞毒性作用而发展出的一些机制,重点是三唑类。

相似文献

1
Fundamental Concepts of Azole Compounds and Triazole Antifungals: A Beginner's Review.唑类化合物和三唑类抗真菌药物的基本概念:初学者综述
P R Health Sci J. 2018 Sep;37(3):135-142.
2
[New systemic antifungal drugs: mechanisms of action, drug interactions and side effects].新型全身性抗真菌药物:作用机制、药物相互作用及副作用
Mycoses. 2003;46 Suppl 1:28-31.
3
A new, broad-spectrum azole antifungal: posaconazole--mechanisms of action and resistance, spectrum of activity.一种新型广谱唑类抗真菌药:泊沙康唑——作用机制与耐药性、活性谱
Mycoses. 2006;49 Suppl 1:2-6. doi: 10.1111/j.1439-0507.2006.01295.x.
4
Medically important fungi respond to azole drugs: an update.具有医学重要性的真菌对唑类药物的反应:最新进展
Future Microbiol. 2015;10(8):1355-73. doi: 10.2217/FMB.15.47. Epub 2015 Aug 3.
5
New antifungal agents.新型抗真菌药物。
Eur J Clin Microbiol Infect Dis. 1989 May;8(5):402-12. doi: 10.1007/BF01964056.
6
Azole antimycotics--a highway to new drugs or a dead end?唑类抗真菌药物——新药之路还是死胡同?
Curr Med Chem. 2012;19(9):1378-88. doi: 10.2174/092986712799462621.
7
Pharmacology and clinical use of voriconazole.伏立康唑的药理学与临床应用。
Expert Opin Drug Metab Toxicol. 2010 Jan;6(1):83-94. doi: 10.1517/17425250903463878.
8
Azole antifungals: 35 years of invasive fungal infection management.唑类抗真菌药物:侵袭性真菌感染管理的35年
Expert Rev Anti Infect Ther. 2015 Jun;13(6):787-98. doi: 10.1586/14787210.2015.1032939. Epub 2015 Apr 5.
9
Posaconazole: a new broad-spectrum antifungal agent.泊沙康唑:一种新型广谱抗真菌药物。
Expert Opin Pharmacother. 2007 Jun;8(8):1167-78. doi: 10.1517/14656566.8.8.1167.
10
Azole antifungal agents: emphasis on new triazoles.唑类抗真菌药物:重点介绍新型三唑类药物。
Antimicrob Agents Chemother. 1988 Jan;32(1):1-8. doi: 10.1128/AAC.32.1.1.

引用本文的文献

1
Assessment of the potential risk of oteseconazole and two other tetrazole antifungals to inhibit adrenal steroidogenesis and peripheral metabolism of corticosteroids.评估奥替康唑和其他两种四氮唑类抗真菌药抑制肾上腺类固醇生成及皮质类固醇外周代谢的潜在风险。
Front Pharmacol. 2024 Aug 8;15:1394846. doi: 10.3389/fphar.2024.1394846. eCollection 2024.
2
Characterization and In Vitro Fungicide Sensitivity of Two spp. Associated with Stem Rot of Dragon Fruit in Guizhou, China.中国贵州与火龙果茎腐病相关的两种病原菌的鉴定及体外杀真菌剂敏感性研究
J Fungi (Basel). 2023 Dec 8;9(12):1178. doi: 10.3390/jof9121178.
3
Antifungal chemotherapies and immunotherapies for the future.
未来的抗真菌化学疗法和免疫疗法。
Parasite Immunol. 2023 Feb;45(2):e12960. doi: 10.1111/pim.12960. Epub 2022 Dec 18.
4
Novel 1, 2, 4-Triazoles as Antifungal Agents.新型 1,2,4-三唑类抗真菌剂。
Biomed Res Int. 2022 Mar 22;2022:4584846. doi: 10.1155/2022/4584846. eCollection 2022.
5
Synthesis, Optimization, Antifungal Activity, Selectivity, and CYP51 Binding of New 2-Aryl-3-azolyl-1-indolyl-propan-2-ols.新型2-芳基-3-唑基-1-吲哚基-丙-2-醇的合成、优化、抗真菌活性、选择性及与CYP51的结合
Pharmaceuticals (Basel). 2020 Aug 8;13(8):186. doi: 10.3390/ph13080186.
6
Current Antimycotics, New Prospects, and Future Approaches to Antifungal Therapy.当前的抗真菌药物、新前景及抗真菌治疗的未来方法
Antibiotics (Basel). 2020 Jul 25;9(8):445. doi: 10.3390/antibiotics9080445.
7
The Connection of Azole Fungicides with Xeno-Sensing Nuclear Receptors, Drug Metabolism and Hepatotoxicity.唑类抗真菌剂与外源性感知核受体、药物代谢和肝毒性的关联。
Cells. 2020 May 11;9(5):1192. doi: 10.3390/cells9051192.
8
A Ketoconazole Susceptibility Test for Using Modified Leeming⁻Notman Agar.使用改良的利明-诺特曼琼脂进行酮康唑药敏试验。
J Fungi (Basel). 2018 Nov 16;4(4):126. doi: 10.3390/jof4040126.